Skip to content

A Randomized Controlled Trial on Smoking Cessation and Adherence Intervention on Patients With Erectile Dysfunction

A Randomized Controlled Trial on Smoking Cessation and Adherence Intervention on Patients With Erectile Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00563511
Enrollment
1210
Registered
2007-11-26
Start date
2004-01-31
Completion date
2006-08-31
Last updated
2011-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

smoking cessation

Brief summary

The purpose of this proposed RCT is to test (a) the effectiveness of smoking cessation intervention (counseling and NRT) among patients with ED; and (b) the effectiveness of adherence intervention (ADIN) to increase adherence to NRT use in order to increase quit rate.

Interventions

PROCEDUREintervention without adherence advice
PROCEDUREcontrol

Sponsors

The University of Hong Kong
CollaboratorOTHER
Hospital Authority, Hong Kong
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
SINGLE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* Male ethnic Chinese aged 18 or above * Smokes at least 1 cigarette per day * Is not following other forms of smoking cessation interventions * Intends to quit smoking within the next 7 days of the first contact and would use NRT * Free from illness that contraindicate to the use of NRT * Has signed an informed consent form, or has given verbal consent (for those contacted by telephone)

Exclusion criteria

* Patients who are psychologically or physically unable to communicate * Children and teenagers (aged below 18) * Those on regular psychotropic medications and in the presence of any serious health problems that may make them unsuitable for using NRT, such as recent stroke, palpitation, or other life threatening conditions

Design outcomes

Primary

MeasureTime frame
quit rate6-month
adherence rate4-weeks after the first use of NRT

Secondary

MeasureTime frame
erectile function6-month
use of NRT3-month
quit rate3-month

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026